Ticker LaunchUplisting · GOVX
GeoVax Labs, Inc.
Formerly DAUPHIN TECHNOLOGY INC
GeoVax Labs, Inc. (GOVX), already reporting to the SEC, moved up to Nasdaq Capital Market on Sep 28, 2020 with an offering at $5.00 per share raising $12.8M. Maxim Group was lead-left underwriter, joined by Joseph Gunnar. Womble Bond Dickinson (US) advised the company and Lucosky Brookman advised the underwriters.
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancers using its MVA-based virus-like particle vector platform. Its programs include COVID-19 vaccine candidates, as well as vaccines against HIV, hemorrhagic fever viruses, Zika and malaria.
- Status
- Uplisting
- Ticker
- GOVX
- Exchange
- Nasdaq Capital Market
- Listed
- Sep 28, 2020
- Price
- $5.00
- Price range
- $5.00–$7.00
- Raised
- $12.8M
- Market cap at IPO price
- $17.8M
- First filed
- Sep 12, 1996
- Underwriters
- Maxim Group and Joseph Gunnar
- Company counsel
- Womble Bond Dickinson (US)
- Underwriters' counsel
- Lucosky Brookman
- Sector
- Biotech & pharma
- Country / state
- GA
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 12, 1996
- Latest amendment Sep 24, 2020
- Final prospectus (424B4) Sep 28, 2020
- All filings on EDGAR CIK 832489
Other Biotech & pharma uplistings in 2020
- Cyclo Therapeutics, Inc.CTDH · Dec 11, 2020 · $12.5M
- Nomad Power Solutions, Inc.LIXT · Nov 27, 2020
- Processa Pharmaceuticals, Inc.PCSA · Oct 5, 2020 · $19.2M
- Biovie Inc.BIVI · Sep 18, 2020 · $15.7M
- Panbela Therapeutics, Inc.SNBP · Aug 31, 2020
- Windtree Therapeutics Inc /de/WINTD · May 21, 2020 · $20M